Dhanuka Agritech Past Earnings Performance
Past criteria checks 2/6
Dhanuka Agritech has been growing earnings at an average annual rate of 8.2%, while the Chemicals industry saw earnings growing at 6.7% annually. Revenues have been growing at an average rate of 8.8% per year. Dhanuka Agritech's return on equity is 17.1%, and it has net margins of 13.9%.
Key information
8.23%
Earnings growth rate
9.16%
EPS growth rate
| Chemicals Industry Growth | 17.68% |
| Revenue growth rate | 8.84% |
| Return on equity | 17.08% |
| Net Margin | 13.92% |
| Last Earnings Update | 31 Mar 2026 |
Recent past performance updates
Recent updates
Narrative Update • May 03
507717: Upcoming Director Appointment Will Support Future Upside Confidence
Analysts have nudged their price target on Dhanuka Agritech slightly higher, with fair value moving from ₹1,426.00 to about ₹1,439.57, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. What's in the News A postal ballot based Special or Extraordinary Shareholders Meeting is scheduled for March 19, 2026, in India (Key Developments).Narrative Update • Apr 18
507717: Upcoming Governance And Earnings Dates Will Support Future Upside Confidence
Analysts have trimmed their price target on Dhanuka Agritech slightly from ₹1,438.50 to ₹1,426.00, reflecting updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News Special or Extraordinary Shareholders Meeting scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (company filing).Narrative Update • Apr 03
507717: Upcoming Governance And Earnings Dates Will Support Upside Confidence
Analysts have kept their price target for Dhanuka Agritech steady at around ₹1,438, reflecting largely unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dhanuka Agritech has scheduled a Special or Extraordinary Shareholders Meeting via postal ballot in India on March 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (Key Developments).Narrative Update • Mar 19
507717: Upcoming Meetings Will Reinforce Confidence In Sustained Upside Potential
Analysts have kept the price target for Dhanuka Agritech broadly steady at around ₹1,438, with only minor model tweaks to the discount rate and the assumed future P/E driving the small change. What's in the News A Special or Extraordinary shareholders meeting is scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an independent director for a first term of 5 years (company filing).Narrative Update • Mar 05
507717: Upcoming Meetings Will Support Confidence In Long-Term Upside Potential
Analysts have maintained their ₹1,438.50 price target for Dhanuka Agritech and made only minor adjustments to their assumptions on discount rate, revenue growth, profit margin and future P/E. These limited changes suggest that their overall valuation framework remains broadly consistent with earlier assessments.
New Narrative • Feb 21
Rural Distribution And Biostimulant Tailwinds Will Support A Stronger Long Term Outlook
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection and allied products to farmers across major agricultural regions in India. What are the underlying business or industry changes driving this perspective?Narrative Update • Feb 19
507717: Upcoming Board And Shareholder Meetings Will Support Long-Term Upside Potential
Analysts have revised their price target on Dhanuka Agritech from ₹1,571.75 to ₹1,438.50, reflecting updated assumptions around the discount rate, expected revenue growth, profit margin and future P/E multiples. What's in the News Dhanuka Agritech has scheduled a Board Meeting on Feb 05, 2026, at 13:00 Indian Standard Time to consider and approve the financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
New Narrative • Feb 06
Dahej Ramp Up Risks And Regulatory Setbacks Will Eventually Support A Stronger Business
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection products and related offerings to farmers across major agricultural regions. What are the underlying business or industry changes driving this perspective?Narrative Update • Feb 04
507717: Stable Assumptions And Upcoming Results Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,571.75, citing broadly consistent assumptions for the discount rate, revenue growth, profit margin and future P/E in their refreshed model. What's in the News Dhanuka Agritech has scheduled a board meeting on Feb 05, 2026.Narrative Update • Jan 21
507717: Higher Margin Outlook Will Support Long-Term Upside Potential
Analysts have trimmed their price target for Dhanuka Agritech by ₹35 to ₹1,571.75. This reflects updated views on slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to future P/E expectations, partly offset by a marginally higher profit margin outlook.Narrative Update • Jan 06
507717: Nagpur Plant Land Purchase Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,606.75, with only minor tweaks to inputs such as the discount rate, revenue growth, profit margin, and future P/E assumptions guiding their view. What's in the News Board meeting scheduled on Oct 31, 2025 at 11:00 Indian Standard Time to review and approve financial results for the quarter and half year ended Sep 30, 2025 (company filing).Narrative Update • Dec 16
507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential
Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple. What's in the News Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing) Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing) Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing) Valuation Changes The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.Narrative Update • Dec 02
507717: Upcoming Nagpur Plant And Board Actions Will Fuel Long-Term Momentum
Analysts have maintained their fair value estimate for Dhanuka Agritech at ₹1,638, citing stable projections for growth and profitability despite minor adjustments in underlying assumptions. What's in the News Dhanuka Agritech will hold a Board Meeting on October 31, 2025, at 11:00 Indian Standard Time (Board Meeting announcement).Narrative Update • Nov 17
507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion
Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.Narrative Update • Nov 03
507717: New Nagpur Plant And Higher Margins Will Drive Future Upside
Analysts have revised their price target for Dhanuka Agritech downward from ₹1,875 to ₹1,779.88. This adjustment reflects updated projections in revenue growth and profit margins, as well as a slightly reduced future valuation multiple.Narrative Update • Sep 05
Improved Monsoon Trends And Capacity Expansion Will Drive Agrochemicals Demand
With both the discount rate and future P/E essentially unchanged, analysts maintained Dhanuka Agritech’s fair value at ₹1875. What's in the News Board meeting scheduled to consider and approve financial results for the quarter ended 30 June, 2025.
New Narrative • Feb 09
Acquiring Rights To Iprovalicarb And Triadimenol Will Open International Markets
International expansion and product innovation could boost revenue through new market entry, geographic diversification, and premium pricing for unique solutions.Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Dhanuka Agritech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 20,628 | 2,872 | 1,898 | 0 |
| 31 Dec 25 | 19,785 | 2,650 | 1,993 | 0 |
| 30 Sep 25 | 20,138 | 2,800 | 1,967 | 0 |
| 30 Jun 25 | 20,699 | 3,036 | 1,955 | 0 |
| 31 Mar 25 | 20,352 | 2,970 | 1,917 | 0 |
| 31 Dec 24 | 19,614 | 2,805 | 1,881 | 0 |
| 30 Sep 24 | 19,194 | 2,708 | 1,858 | 0 |
| 30 Jun 24 | 18,831 | 2,550 | 1,832 | 0 |
| 31 Mar 24 | 17,585 | 2,391 | 1,745 | 0 |
| 31 Dec 23 | 17,615 | 2,454 | 1,612 | 0 |
| 30 Sep 23 | 17,516 | 2,461 | 1,522 | 0 |
| 30 Jun 23 | 16,766 | 2,173 | 1,426 | 0 |
| 31 Mar 23 | 17,002 | 2,335 | 1,442 | 0 |
| 31 Dec 22 | 16,473 | 2,226 | 1,399 | 0 |
| 30 Sep 22 | 16,108 | 2,191 | 1,387 | 0 |
| 30 Jun 22 | 15,067 | 2,094 | 1,380 | 0 |
| 31 Mar 22 | 14,778 | 2,089 | 1,352 | 0 |
| 31 Dec 21 | 14,350 | 2,031 | 1,324 | 0 |
| 30 Sep 21 | 13,738 | 2,007 | 1,293 | 0 |
| 30 Jun 21 | 13,774 | 2,074 | 1,293 | 0 |
| 31 Mar 21 | 13,875 | 2,106 | 1,314 | 0 |
| 31 Dec 20 | 13,395 | 2,009 | 1,237 | 0 |
| 30 Sep 20 | 13,153 | 1,886 | 1,234 | 0 |
| 30 Jun 20 | 12,749 | 1,785 | 1,131 | 0 |
| 31 Mar 20 | 11,201 | 1,413 | 1,128 | 0 |
| 31 Dec 19 | 10,852 | 1,291 | 1,185 | 0 |
| 30 Sep 19 | 10,305 | 1,160 | 1,156 | 0 |
| 30 Jun 19 | 10,118 | 1,111 | 1,163 | 0 |
| 31 Mar 19 | 10,058 | 1,126 | 1,174 | 0 |
| 31 Dec 18 | 9,982 | 1,145 | 1,255 | 0 |
| 30 Sep 18 | 10,029 | 1,285 | 1,294 | 0 |
| 30 Jun 18 | 9,676 | 1,262 | 1,253 | 0 |
| 31 Mar 18 | 9,626 | 1,262 | 1,246 | 0 |
| 31 Dec 17 | 9,265 | 1,201 | 1,189 | 0 |
| 30 Sep 17 | 9,168 | 1,183 | 1,156 | 0 |
| 30 Jun 17 | 8,812 | 1,156 | 1,132 | 0 |
| 31 Mar 17 | 8,833 | 1,219 | 1,118 | 0 |
| 31 Dec 16 | 8,886 | 1,237 | 1,152 | 0 |
| 30 Sep 16 | 8,857 | 1,196 | 1,102 | 0 |
| 30 Jun 16 | 8,469 | 1,081 | 1,061 | 0 |
| 31 Mar 16 | 8,289 | 1,073 | 1,003 | 0 |
| 31 Dec 15 | 8,116 | 1,007 | 1,483 | 10 |
| 30 Sep 15 | 7,850 | 1,002 | 684 | 0 |
| 30 Jun 15 | 7,977 | 1,042 | 662 | 0 |
Quality Earnings: 507717 has high quality earnings.
Growing Profit Margin: 507717's current net profit margins (13.9%) are lower than last year (14.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 507717's earnings have grown by 8.2% per year over the past 5 years.
Accelerating Growth: 507717's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 507717 had negative earnings growth (-3.3%) over the past year, making it difficult to compare to the Chemicals industry average (10.4%).
Return on Equity
High ROE: 507717's Return on Equity (17.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/22 17:54 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dhanuka Agritech Limited is covered by 17 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |